Long-term outcome of high-grade serous carcinoma established in risk-reducing salpingo-oophorectomy specimens in asymptomatic BRCA1/2 germline pathogenic variant carriers
Authors:
Open Access
- 24 May 2024
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 187, 198-203
Abstract
No abstract availableKeywords
Funding Information
- Pink Ribbon Foundation
- KWF Kankerbestrijding (NKI2007-3756, NKI1998-1854)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek (2014-187, 184.021.007/CP46, 12-054, 110005, NWO 91109024)
This publication has 20 references indexed in Scilit:
- The most efficient and effective BRCA1/2 testing strategy in epithelial ovarian cancer: Tumor-First or Germline-First?Gynecologic Oncology, 2023
- Clinical commentary: Extra-uterine high-grade serous carcinoma: two pathways, two preventions?Gynecologic Oncology, 2022
- Outcomes of incidentally detected ovarian cancers diagnosed at time of risk-reducing salpingo-oophorectomy in BRCA mutation carriersGynecologic Oncology, 2021
- Ovarian cancerThe Lancet, 2014
- Long term follow up of BRCA1 and BRCA2 mutation carriers with unsuspected neoplasia identified at risk reducing salpingo-oophorectomyGynecologic Oncology, 2013
- Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and MortalityJAMA, 2010
- Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersBreast Cancer Research and Treatment, 2010
- Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation CarriersNew England Journal of Medicine, 2009
- Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?International Journal of Cancer, 2008
- Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-upBritish Journal of Cancer, 2004